Northern Trust
IDXG

Northern Trust’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Northern Trust’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,731
Closed -$43K – 4331
2019
Q4 		$43K Sell
8,731
-94
-1% -$608 ﹤0.01% 4082
2019
Q3 		$70K Hold
8,825
– – ﹤0.01% 3997
2019
Q2 		$64K Hold
8,825
– – ﹤0.01% 4042
2019
Q1 		$70K Buy
8,825
+1,900
+27% +$17.9K ﹤0.01% 3989
2018
Q4 		$55K Sell
6,925
-20
-0.3% -$240 ﹤0.01% 4035
2018
Q3 		$107K Buy
6,945
+4,319
+164% +$52K ﹤0.01% 4013
2018
Q2 		$23K Hold
2,626
– – ﹤0.01% 4206
2018
Q1 		$23K Hold
2,626
– – ﹤0.01% 4157
2017
Q4 		$27K Buy
2,626
+22
+0.8% +$266 ﹤0.01% 4133
2017
Q3 		$40K Buy
+2,604
New +$30.7K ﹤0.01% 4091
2016
Q4 		– Sell
-288
Closed -$4K – 4221
2016
Q3 		$4K Hold
288
– – ﹤0.01% 4163
2016
Q2 		$10K Hold
288
– – ﹤0.01% 4164
2016
Q1 		$8K Hold
288
– – ﹤0.01% 4183
2015
Q4 		$13K Hold
288
– – ﹤0.01% 4196
2015
Q3 		$52K Buy
288
+27
+10% +$5.32K ﹤0.01% 4065
2015
Q2 		$37K Sell
261
-23
-8% -$3.19K ﹤0.01% 4100
2015
Q1 		$39K Sell
284
-26
-8% -$4.25K ﹤0.01% 4181
2014
Q4 		$55K Sell
310
-161
-34% -$28.6K ﹤0.01% 4080
2014
Q3 		$113K Sell
471
-162
-26% -$54.1K ﹤0.01% 4002
2014
Q2 		$277K Buy
633
+9
+1% +$4.15K ﹤0.01% 3760
2014
Q1 		$285K Buy
624
+19
+3% +$9.87K ﹤0.01% 3694
2013
Q4 		$291K Sell
605
-2
-0.3% -$978 ﹤0.01% 3625
2013
Q3 		$292K Sell
607
-739
-55% -$354K ﹤0.01% 3558
2013
Q2 		$633K Buy
+1,346
New +$610K ﹤0.01% 3407

Other funds holding IDXG

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Northern Trust's IDXG Position: Q1 2020 in Review

Northern Trust sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2020, closing a stake of 8,731 shares — an estimated $43K sold.

Northern Trust first reported a position in IDXG in Q2 2013 and held it in 24 quarters. The position peaked at $633K in Q2 2013. 15 funds tracked by Wall St. Rank hold IDXG as of Q1 2020.

  • Northern Trust reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Northern Trust sold 8,731 Interpace Biosciences, Inc. Common Stock shares in Q1 2020, an estimated $43K.
  • Northern Trust first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 24 quarters.
  • Northern Trust's Interpace Biosciences, Inc. Common Stock position peaked at $633K in Q2 2013.
  • 15 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2020.

Based on Northern Trust's 13F filing for Q1 2020, filed 14 May 2020.